The results suggested that LEPR gene G3057 A (rs1805096) polymorphism may be involved in NAFLD by regulating lipid metabolism and affecting insulin sensitivity in patients with T2DM [43]. The gene discussed is LEPR; the disease is metabolic dysfunction-associated steatotic liver disease.